28 results
8-K
EX-1.1
VKTX
Viking Therapeutics Inc
1 Mar 24
Viking Therapeutics Announces Pricing of $550 Million Public Offering of Common Stock
4:05pm
but not limited to the federal TRICARE statute (10 U.S.C. Section 1071 et seq.), the Veterans Administration drug pricing program (38 U.S.C. Section
8-K
EX-1.1
q7k alkeck22i5
31 Mar 23
Viking Therapeutics Announces Pricing of $250 Million Public Offering of Common Stock
5:27pm